Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Total Non-Current Liabilities: 2010-2020

Historic Total Non-Current Liabilities for Neurocrine Biosciences (NBIX) over the last 10 years, with Dec 2020 value amounting to $598.8 million.

  • Neurocrine Biosciences' Total Non-Current Liabilities fell 4.47% to $663.0 million in Q3 2021 from the same period last year, while for Sep 2021 it was $663.0 million, marking a year-over-year decrease of 4.47%. This contributed to the annual value of $598.8 million for FY2020, which is 8.16% down from last year.
  • Latest data reveals that Neurocrine Biosciences reported Total Non-Current Liabilities of $598.8 million as of FY2020, which was down 8.16% from $652.0 million recorded in FY2019.
  • Neurocrine Biosciences' 5-year Total Non-Current Liabilities high stood at $652.0 million for FY2019, and its period low was $50.1 million during FY2016.
  • For the 3-year period, Neurocrine Biosciences' Total Non-Current Liabilities averaged around $575.8 million, with its median value being $598.8 million (2020).
  • As far as peak fluctuations go, Neurocrine Biosciences' Total Non-Current Liabilities surged by 36.77% in 2019, and later declined by 8.16% in 2020.
  • Neurocrine Biosciences' Total Non-Current Liabilities (Yearly) stood at $50.1 million in 2016, then reached $476.7 million in 2018, then surged by 36.77% to $652.0 million in 2019, then fell by 8.16% to $598.8 million in 2020.